MedTrace Logo

Uncertainty and Firearms: Obtaining Secure Storage

NCT05818696 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-02-24

No results posted yet for this study

Summary

The goal of this clinical trial is to test whether inclusion of cognitive behavioral therapy (CBT) for Uncertainty-Enhanced (CUE) with Lethal Means Counseling (LMC) is acceptable, feasible, and efficacious in addressing secure firearm storage and associated psychological constructs in active duty servicemembers. The clinical trial aims to:

* Assess the preliminary efficacy of a LMC intervention, augmented with CUE, on firearm storage practices
* Examine mechanisms through which CUE and LMC increase firearm storage practices
* Assess credibility and acceptability of LMC

Participants will complete:

* One baseline visit
* Two intervention sessions-CUE and LMC
* Six brief surveys per day for 28 days using a mobile application
* One mid-point survey and five follow-up surveys

Conditions

Interventions

BEHAVIORAL

Lethal Means Counseling (LMC)

The research interventionist uses a guiding approach to identify methods for secure firearm storage and reflects the participant's reasons for and against secure firearm storage, with a particular focus on the service member's verbalized reasons for wanting to adopt or use the identified storage methods.

BEHAVIORAL

CBT for Uncertainty - Enhanced (CUE)

CUE consists of a 1-hour manualized intervention that uses interactive content to enhance participant learning of critical intervention components. The session includes (1) psychoeducation regarding the role of IU in exacerbating anxiety/mood sensations, (2) practice identifying and challenging maladaptive thoughts about uncertainty and accompanying distress, and (3) behavioral activities to challenge participants' capacity to handle uncertainty.

Sponsors & Collaborators

  • Rutgers University

    collaborator OTHER

  • Ohio State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-26
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05818696 on ClinicalTrials.gov